Omada Health, Inc. Common Stock (OMDA)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Omada Health, Inc. Common Stock.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 19.80 $ — 56% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
8 of 10 Growth gemTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 42.9% passed
- More than 10% revenue growth is expected for the coming year 19.9% passed
- Share count grows by less than 3% a year 1.6% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 59.8% passed
- Gross margin at 40% or higher and without meaningful erosion 65.7% passed
- Goodwill from acquisitions does not grow faster than revenue 4.3% passed
- Net debt below twice EBITDA 222 m net cash passed
- Operating cash flow covers the profits of the last three years 62 m passed
- Return on capital at 15% or higher, or up versus two years ago -5.2% failed
- Insiders hold at least 10% or are net buyers 2.3% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 15.8% above the current price.
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Next Reporting Date
- Expected Earnings per Share
- -0.01 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.15 | – | 48 | 47.40 | -17.20 | -7 | -8 |
| 2025: Q1 | -0.17 | – | 55 | 56.60 | -17.20 | -16 | -17 |
| 2025: Q2 | -0.09 | – | 61 | 48.90 | -8.70 | 3 | 3 |
| 2025: Q3 | -0.06 | – | 68 | 49.50 | -4.70 | 10 | 10 |
| 2025: Q4 | 0.09 | – | 76 | 58.10 | 6.80 | 21 | 21 |
| 2026: Q1 | -0.05 | – | 78 | 42.00 | -3.80 | -12 | -12 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
About the Company
Omada Health, Inc. zusammen mit seiner Tochtergesellschaft Physera, Inc.
| CEO Insider Trades (12 Mo.) | selling own stock |
|---|---|
| Employees | 943 |
| Headquarters | South San Francisco, CA |
| Website | omadahealth.com |
| IPO Date | 6. Jun 2025 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Sean P. Duffy | Co-Founder, CEO & Director | 1984 |
| Wei-Li Shao | President | 1971 |
| Steven L. Cook | Chief Financial Officer | 1986 |
| Lauren Fix | Senior Vice President of Corporate Strategy & Operations | – |
| Craig Gracey | Chief Accounting Officer | 1991 |
| Sunil Kayiti | Chief Technology Officer | – |
| Allan Kells | Vice President of Investor Relations | – |
| Nathan Salha | General Counsel | – |
| Nancy Vitale | Chief People Officer | 1971 |
| Jennifer Becker | Chief Care Delivery Operating Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Cook Steven L. | Chief Financial Officer | Sell | 11,750 | 24.01 | 282,174 |
| 15. Jul 2026 | Cook Steven L. | Chief Financial Officer | Sell | 400 | 24.00 | 9,600 |
| 15. Jul 2026 | Cook Steven L. | Chief Financial Officer | Other | 12,150 | 8.28 | 100,602 |
| 13. Jul 2026 | Gracey Craig | Chief Accounting Officer | Sell | 1,041 | 24.00 | 24,984 |
| 13. Jul 2026 | Gracey Craig | Chief Accounting Officer | Other | 1,041 | 6.57 | 6,839 |
| 13. Jul 2026 | Cook Steven L. | Chief Financial Officer | Sell | 600 | 24.01 | 14,406 |
| 13. Jul 2026 | Cook Steven L. | Chief Financial Officer | Sell | 5,200 | 24.00 | 124,800 |
| 13. Jul 2026 | Cook Steven L. | Chief Financial Officer | Other | 5,800 | 8.28 | 48,024 |
| 7. Jul 2026 | Cook Steven L. | Chief Financial Officer | Sell | 12,337 | 23.09 | 284,840 |
| 7. Jul 2026 | Cook Steven L. | Chief Financial Officer | Other | 694 | 7.68 | 5,330 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.